NFKB1 and chronic lung disease: These findings lay the groundwork for future investigations into the modulation of the Nrf2/NF-κB axis and the interplay between fumarates and metalloproteinase inhibitors, aiming to develop more effective therapeutic strategies for managing pulmonary emphysema and other chronic lung diseases.